Frontlight ResearchEarly access
Childhood cancers trials in Japan
16 of 48 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therapy
- Where
- Bunkyo Ku, Kurume, Osaka, Suita
- Age
- 15 years to 15 years
- People
- 30
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07378969 - Phase 2Enrolling by invitationLong-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
- Where
- Fukuoka, Kyoto, Okayama, Sapporo Hokkaido, Sendai, Tokyo
- People
- 1,500 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00 - No phaseTaking peopleAcute Ischemic Stroke in Patients With Active Cancer
- Where
- Suita
- People
- 500
- Run by
- Osaka University
See details and how to joinNCT07819526 - No phaseTaking peopleRepotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in Japan
- Where
- Minato-ku, Tokyo
- Age
- 4 years to 17 years
- People
- 20
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07755826 - No phaseTaking peopleNTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes
- Where
- Multiple Locations
- People
- 100
- Run by
- Bayer
See details and how to joinNCT04945330 - No phaseTaking peopleSpecial Drug Use-results Surveillance of Tafinlar/Mekinist
- Where
- Akita, Amagasaki, Bunkyo Ku, Chiba, Chuo Ku, Daisen, Fukuoka, Fukuyama, Funabashi, Habikino, Hiroshima, Iida, Izumisano, Kagoshima, Kashiwa, Kawagoe, Kobe, Kochi, Kurume, Kyoto, Matsumoto, Minato Ku, Mito, Morioka, Nagakute, Nagoya, Natori-shi, Ohtsu, Okayama, Osaka, Sagamihara, Saitama, Sapporo, Sendai, Setagaya-ku, Shibuya City, Shimotsuke, Shinjuku Ku, Shizuoka, Sunto Gun, Takatsuki, Toyohashi, Toyota, Wakayama, Yamagata, Yokohama, Yoshida-gun, Yufu
- Age
- 6 years to 99 years
- People
- 110
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06262919 - No phaseTaking peopleA Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
- Where
- Tokyo
- Age
- Up to 18 years
- People
- 8
- Run by
- Takeda
See details and how to joinNCT05481437 - No phaseTaking peopleSurvey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
- Where
- Tokyo
- People
- 500
- Run by
- Takeda
See details and how to joinNCT05100069 - No phaseTaking peopleMulti-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
- Where
- Nagoya
- People
- 1,050 worldwide
- Run by
- Washington University School of Medicine
See details and how to joinNCT03141021 - No phaseTaking peopleA Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
- Where
- Tokyo
- People
- 60
- Run by
- Eisai Co., Ltd.
See details and how to joinNCT06793709 - No phaseTerminatedPrimary Tumor Research and Outcomes Network
- Where
- Kanazawa
- People
- 1,350 worldwide
- Run by
- AO Innovation Translation Center
See details and how to joinNCT02790983 - No phaseNot yet taking people in JapanAsian Gynecological Brachytherapy Registry in Cervical Cancer
- Where
- Maebashi, Tokyo
- People
- 1,000 worldwide
- Run by
- Tata Memorial Hospital
See details and how to joinNCT07196033 - No phaseTaking peopleTransgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Where
- Kumamoto, Toyokawa
- People
- 50 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06357754 - No phaseTaking peopleID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
- Where
- Tokyo
- People
- 2,000 worldwide
- Run by
- Stanford University
See details and how to joinNCT02848274 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Tokyo
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseNot yet taking people in JapanInternational Chronic Myeloid Leukemia Pediatric Study
- Where
- Tokyo
- Age
- Up to 18 years
- People
- 750 worldwide
- Run by
- Poitiers University Hospital
See details and how to joinNCT01281735